Kristina Ellwanger

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Selection of bispecific antibodies with optimal developability using FcRn‑Ph‑HPLC as an optimized FcRn affinity chromatography method.

Selection of bispecific antibodies with optimal developability using FcRn‑Ph‑HPLC as an optimized FcRn affinity chromatography method.

Journal: mAbs
Published: August 21, 2023

Cryopreservation of Natural Killer Cells Pre-Complexed with Innate Cell Engagers.

Cryopreservation of Natural Killer Cells Pre-Complexed with Innate Cell Engagers.

Journal: Antibodies (Basel, Switzerland)
Published: December 20, 2021

A BCMA/CD16A bispecific innate cell engager for the treatment of multiple myeloma.

A BCMA/CD16A bispecific innate cell engager for the treatment of multiple myeloma.

Journal: Leukemia
Published: August 05, 2021

Preclinical evaluation of AFM24, a novel CD16A-specific innate immune cell engager targeting EGFR-positive tumors.

Preclinical evaluation of AFM24, a novel CD16A-specific innate immune cell engager targeting EGFR-positive tumors.

Journal: mAbs
Published: July 30, 2021

Redirected optimized cell killing (ROCK®): A highly versatile multispecific fit-for-purpose antibody platform for engaging innate immunity.

Redirected optimized cell killing (ROCK®): A highly versatile multispecific fit-for-purpose antibody platform for engaging innate immunity.

Journal: mAbs
Published: June 08, 2019

Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies.

Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies.

Journal: Frontiers in oncology
Published: February 01, 2017

Trispecific antibodies for CD16A-directed NK cell engagement and dual-targeting of tumor cells.

Trispecific antibodies for CD16A-directed NK cell engagement and dual-targeting of tumor cells.

Journal: Protein engineering, design & selection : PEDS
Published: December 28, 2016

Characterization of CD33/CD3 Tetravalent Bispecific Tandem Diabodies (TandAbs) for the Treatment of Acute Myeloid Leukemia.

Characterization of CD33/CD3 Tetravalent Bispecific Tandem Diabodies (TandAbs) for the Treatment of Acute Myeloid Leukemia.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 06, 2016

A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells.

A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells.

Journal: mAbs
Published: April 16, 2015

Fate Specification of Neural Plate Border by Canonical Wnt Signaling and Grhl3 is Crucial for Neural Tube Closure.

Fate Specification of Neural Plate Border by Canonical Wnt Signaling and Grhl3 is Crucial for Neural Tube Closure.

Journal: EBioMedicine
Published: January 07, 2015

Loss of Dickkopf-1 restores neurogenesis in old age and counteracts cognitive decline.

Loss of Dickkopf-1 restores neurogenesis in old age and counteracts cognitive decline.

Journal: Cell stem cell
Published: February 21, 2012
Showing 1-11 of 11

Last Updated: 09/26/2026